UnknownNot Applicable

18F-fluorocholine PET/CT Imaging in Hyperparathyroidism

Slovenia1,000 participantsStarted 2013-01-01

Plain-language summary

To assess the efficiency of 18F-fluorocholine PET/CT in localization of hyperfunctioning parathyroid tissue in hyperparathyroidism, thereby enabling minimally invasive surgical approaches with fewer complications and comparable success rates

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age over 18 years * Biochemically proven hyperparathyroidism (elevated iPTH, elevated on normal Ca2+) or elevated Ca2+ and inadequately supressed iPTH Exclusion Criteria: * Age under 18 years * Pregnancy * Clinical history of oncological, inflammatory/infectious disease of the head and neck

What they're measuring

Sensitivity & Specificity

Timeframe: 3 months

Trial details

NCT IDNCT03203668

SponsorUniversity Medical Centre Ljubljana

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-31

Contact for this trial

Luka Lezaic, MD PhD

+386 1 522 84 50 luka.lezaic@kclj.si

View on ClinicalTrials.gov More Hyperparathyroidism trials